Article Text

Download PDFPDF
Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Funding The clinical part of this study was partially financed by Abbott. This investigation was also facilitated by the Clinical Research Bureau of the Jan van Breemen Institute and received financial support from the Dutch Arthritis Foundation.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.